Clinical factors predicting nemolizumab response in atopic dermatitis
Clinical predictors of response to nemolizumab, an anti-IL-31 receptor A antibody, were evaluated in patients with atopic dermatitis (AD). In a retrospective study of 14 Japanese patients, longer disease duration was significantly associated with poor response to treatment. While serum IgE levels an...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-05-01
|
| Col·lecció: | Journal of Allergy and Clinical Immunology: Global |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S277282932500058X |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|